← Leaderboards

Bernhard Josef Hering

University Of Minnesota Twin Cities

Google Scholar ↗PubMed ↗ORCID ↗

$29,197,217

Attributed

$35,948,495

Total exposure

38

Grants

26

Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.

Funding over time

peak $6.6M · FY2005–25

$10M$7.5M$5M$2.5M$0

'05

'06

'07

'08

'09

'10

'11

'12

'13

'14

'15

'16

'17

'18

'19

'20

'21

'22

'23

'24

'25

Funding mix

By agency

NIH$55,162,734 · 41

By mechanism

U01$21,957,733 · 4

U19$16,451,180 · 5

U42$11,449,637 · 6

R01$4,495,633 · 1

R21$426,250 · 1

M01$376,301 · 23

Top collaborators

Most similar at University Of Minnesota Twin Cities

Same institution · by research overlap

John P Bantle$635,626
Michael S Mauer$2,199,497
Zigang Dong$19,250,021

Others in their field

Top investigators on “Transplantation”

Gerald T Nepom · Benaroya Research Inst At Virginia Mason$298,740,071
Mary M Horowitz · Medical College Of Wisconsin$224,924,548
Craig B Thompson · Sloan-Kettering Inst Can Research$157,997,949
Charles A Coltman · Southwest Oncology Group$141,983,231
Richard L Schilsky · University Of Chicago$117,759,216
Harold E Varmus · Sloan-Kettering Institute For Cancer Res$82,854,111

Research focus

TransplantationIsletImmunotherapyProtocols DocumentationIslets Of Langerhans TransplantationInsulinCellsResearch PersonnelClinical ResearchSirolimusPreventT-LymphocyteDiabetes Mellitus TherapyNonhuman PrimatePancreatic Islet TransplantationMaintenanceDiabetes MellitusImmunosuppressive AgentsSourceSafetyChronicResourcesClinical TrialsBase

Grant awards (80)

Advancing Transplantation Tolerance in Nonhuman Primates$3,635,295

U19 · FY2025 · AI

Apoptotic Donor Leukocytes to Promote Kidney Transplant Tolerance$943,403

U19 · FY2025 · AI · contact PI

Advancing Transplantation Tolerance in Nonhuman Primates$3,635,295

U19 · FY2024 · AI

Apoptotic Donor Leukocytes to Promote Kidney Transplant Tolerance$974,638

U19 · FY2024 · AI · contact PI

Advancing Transplantation Tolerance in Nonhuman Primates$3,635,295

U19 · FY2023 · AI

Apoptotic Donor Leukocytes to Promote Kidney Transplant Tolerance$971,375

U19 · FY2023 · AI · contact PI

Deep Immune Profiling of Nonchimeric Tolerance of Transplants in Nonhuman Primates$193,750

R21 · FY2023 · AI · contact PI

Deep Immune Profiling of Nonchimeric Tolerance of Transplants in Nonhuman Primates$232,500

R21 · FY2022 · AI · contact PI

Pig-to-Monkey Islet Xenotransplantation$1,002,980

U01 · FY2019 · AI · contact PI

Pig-to-Monkey Islet Xenotransplantation$1,234,462

U01 · FY2018 · AI · contact PI

Pig-to-Monkey Islet Xenotransplantation$1,161,752

U01 · FY2017 · AI · contact PI

Pig-to-Monkey Islet Xenotransplantation$1,205,659

U01 · FY2016 · AI · contact PI

Alloantigen Delivery Via ECDI-Fixed Cells For Tolerance To Monkey Islet Grafts$869,444

U01 · FY2016 · AI · contact PI

Pig-to-Monkey Islet Xenotransplantation$1,005,885

U01 · FY2015 · AI · contact PI

Alloantigen Delivery Via ECDI-Fixed Cells For Tolerance To Monkey Islet Grafts$999,893

U01 · FY2015 · AI · contact PI

Alloantigen Delivery Via ECDI-Fixed Cells For Tolerance To Monkey Islet Grafts$869,444

U01 · FY2014 · AI · contact PI

Alloantigen Delivery Via ECDI-Fixed Cells For Tolerance To Monkey Islet Grafts$839,012

U01 · FY2013 · AI · contact PI

Alloantigen Delivery Via ECDI-Fixed Cells For Tolerance To Monkey Islet Grafts$869,444

U01 · FY2012 · AI · contact PI

CLINICAL TRIAL: HOKT3g1 (ALA-ALA), SIROLIMUS AND LOW DOSE TACROLIMUS THERAPY IN$38,786

M01 · FY2009 · RR · contact PI

SCREENING PROCEDURE FOR ALLO-ISLET TRANSPLANTATION PROTOCOLS$14,270

M01 · FY2009 · RR · contact PI

EFALIZUMAB (RAPTIVA) COMBINED WITH SIROLIMUS IN TYPE 1 DIABETIC ISLET ALLOGRAFT$13,538

M01 · FY2009 · RR · contact PI

CIT-03: SINGLE-CENTER, OPEN-LABEL CLINICAL TRIAL OF THE EFFICACY OF PERITRANSPLA$8,782

M01 · FY2009 · RR · contact PI

Pig to Non-Human Primate Islet Xenografts$1

U19 · FY2009 · AI · contact PI

Pig to Non-Human Primate Islet Xenografts$1,145,531

U19 · FY2008 · AI · contact PI

HUMAN PANCREATIC ISLET CELL RESOURCES$902,043

U42 · FY2008 · RR · contact PI

Human Pancreatic Islet Cell Resources$854,762

U42 · FY2008 · RR · contact PI

Human Pancreatic Islet Cell Resources$47,281

U42 · FY2008 · RR · contact PI

CLINICAL TRIAL: HOKT3Î|1 (ALA-ALA), SIROLIMUS AND LOW DOSE TACROLIMUS THERA$22,968

M01 · FY2008 · RR · contact PI

SCREENING PROCEDURE FOR ALLO-ISLET TRANSPLANTATION PROTOCOLS$6,626

M01 · FY2008 · RR · contact PI

Advancing Islet Transplants for Type 1 Diabetes Care$1

U01 · FY2008 · AI · contact PI

Human Pancreatic Islet Cell Resources$892,762

U42 · FY2007 · RR · contact PI

HUMAN PANCREATIC ISLET CELL RESOURCES$892,762

U42 · FY2007 · RR · contact PI

SCREENING PROCEDURE FOR ALLO-ISLET TRANSPLANTATION PROTOCOLS$10,473

M01 · FY2007 · RR · contact PI

HOKT3γ1 (ALA-ALA), SIROLIMUS AND LOW DOSE TACROLIMUS THERAPY IN TYPE 1 DIAB$6,733

M01 · FY2007 · RR · contact PI

CTS-IPITA-IXA 2007 Joint Conference$6,000

R13 · FY2007 · AI · contact PI

ANTI-THYMOGLOBUMLIN, CYCLOSPORIN AND RAD IN ISLET TRANSPLANT$4,115

M01 · FY2007 · RR · contact PI

ISLET TRANSPLANTATION IN TYPE 1 DIABETIC PATIENTS USING THE EDMONTON PROTOCOL$517

M01 · FY2007 · RR · contact PI

CIT-03: SINGLE-CENTER, OPEN-LABEL CLINICAL TRIAL OF THE EFFICACY OF PERITRANSPLA$374

M01 · FY2007 · RR · contact PI

Advancing Islet Transplants for Type 1 Diabetes Care$1

U01 · FY2007 · AI · contact PI

Advancing Islet Transplants for Type 1 Diabetes Care$2,432,755

U01 · FY2006 · AI · contact PI

PRECLINICAL MODELS OF ORGAN & CELL TRANSPLANT TOLERANCE$1,510,347

U19 · FY2006 · DK · contact PI

HUMAN PANCREATIC ISLET CELL RESOURCES$1,070,515

U42 · FY2006 · RR · contact PI

Human Pancreatic Islet Cell Resources$910,515

U42 · FY2006 · RR · contact PI

Mixed Chimerism in Haploidentical Non-human Primates$468,451

U01 · FY2006 · DK · contact PI

HUMAN PANCREATIC ISLET CELL RESOURCES (ICRs)$160,000

U42 · FY2006 · RR · contact PI

ANTI-THYMOGLOBUMLIN, CYCLOSPORIN AND RAD IN ISLET TRANSPLANT$80,344

M01 · FY2006 · RR · contact PI

SCREENING PROCEDURE FOR ALLO-ISLET TRANSPLANTATION PROTOCOLS$9,326

M01 · FY2006 · RR · contact PI

ISLET TRANSPLANTATION IN TYPE 1 DIABETIC PATIENTS USING THE EDMONTON PROTOCOL$3,946

M01 · FY2006 · RR · contact PI

Advancing Islet Transplants for Type 1 Diabetes Care$3,335,000

U01 · FY2005 · AI

TOLERANCE TO ISLET ALLOGRAFTS IN TYPE I DIABETES$831,774

R01 · FY2005 · DK

Mixed Chimerism in Haploidentical Non-human Primates$560,222

U01 · FY2005 · DK

HUMAN PANCREATIC ISLET CELL RESOURCES TYPE 1 DIABETES$532,832

U42 · FY2005 · RR

HUMAN PANCREATIC ISLET CELL RESOURCES (ICRs)$492,832

U42 · FY2005 · RR

HUMAN PANCREATIC ISLET CELL RESOURCES (ICRs)$40,000

U42 · FY2005 · RR

ANTI-THYMOGLOBUMLIN, CYCLOSPORIN AND RAD IN ISLET TRANSPLANT$35,013

M01 · FY2005 · RR

ISLET TRANSPLANTATION IN TYPE 1 DIABETIC PATIENTS USING THE EDMONTON PROTOCOL$5,906

M01 · FY2005 · RR

INITIAL VS DELAYED MYCOPHENOLATE MOFETIL IN SINGLE-DONOR ISLET ALLOTRANSPLANTAT$4,218

M01 · FY2005 · RR

HOKT3GAMMAL (ALA-ALA) FOR THE PREVENTION OF HUMAN ISLET ALLOGRAFT FAILURE$1,687

M01 · FY2005 · RR

Advancing Islet Transplants for Type 1 Diabetes Care$3,500,000

U01 · FY2004 · AI

HUMAN PANCREATIC ISLET CELL RESOURCES TYPE 1 DIABETES$1,253,478

U42 · FY2004 · RR

HUMAN PANCREATIC ISLET CELL RESOURCES (ICRs)$1,253,478

U42 · FY2004 · RR

TOLERANCE TO ISLET ALLOGRAFTS IN TYPE I DIABETES$1,148,530

R01 · FY2004 · DK

Mixed Chimerism in Haploidentical Non-human Primates$569,653

U01 · FY2004 · DK

Islet Transplantation in Type 1 Diabetic Patients Using the Edmonton Protocol$39,183

M01 · FY2004 · RR

Anti-thymoglobumlin, Cyclosporin and RAD in Islet Transplant$34,378

M01 · FY2004 · RR

Initial vs. Delayed Mycophenolate Mofetil in Single-Donor Islet Allotransplantan$29,573

M01 · FY2004 · RR

hOKT3gammal (Ala-ala) for the Prevention of Human Islet Allograft Failure$5,545

M01 · FY2004 · RR

TOLERANCE TO ISLET ALLOGRAFTS IN TYPE I DIABETES$962,641

R01 · FY2003 · DK

Mixed Chimerism in Haploidentical Non-human Primates$546,514

U01 · FY2003 · DK

HUMAN PANCREATIC ISLET CELL RESOURCES (ICRs)$200,001

U42 · FY2003 · RR

HUMAN PANCREATIC ISLET CELL RESOURCES (ICRs)$3,622

U42 · FY2003 · RR

HUMAN PANCREATIC ISLET CELL RESOURCES (ICRs)$872,754

U42 · FY2002 · RR

Mixed Chimerism in Haploidentical Non-human Primates$487,161

U01 · FY2002 · DK

IMMUNOTHERAPY AND ISLET REPLACEMENT IN EARLY DIABETES$0

M01 · FY2002 · RR

IMMUNOTHERAPY AND ISLET REPLACEMENT IN EARLY DIABETES$0

M01 · FY2002 · RR

HUMAN PANCREATIC ISLET CELL RESOURCES (ICRs)$1,070,000

U42 · FY2001 · RR

TOLERANCE TO ISLET ALLOGRAFTS IN TYPE I DIABETES$782,709

R01 · FY2001 · DK

IMMUNOTHERAPY AND ISLET REPLACEMENT IN EARLY DIABETES$0

M01 · FY2001 · RR

TOLERANCE TO ISLET ALLOGRAFTS IN TYPE I DIABETES$769,979

R01 · FY2000 · DK

IMMUNOTHERAPY AND ISLET REPLACEMENT IN EARLY DIABETES$0

M01 · FY2000 · RR